Risk of tumorigenicity in mesenchymal stromal cell–based therapies—Bridging scientific observations and regulatory viewpoints
Barkholt, Lisbeth, Flory, Egbert, Jekerle, Veronika, Lucas-Samuel, Sophie, Ahnert, Peter, Bisset, Louise, Büscher, Dirk, Fibbe, Willem, Foussat, Arnaud, Kwa, Marcel, Lantz, Olivier, Mačiulaitis, RomalТом:
15
Мова:
english
Журнал:
Cytotherapy
DOI:
10.1016/j.jcyt.2013.03.005
Date:
July, 2013
Файл:
PDF, 176 KB
english, 2013